The Food and Drug Administration (FDA) has proposed a groundbreaking plan to reduce the amount of nicotine in cigarettes to a ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
In a groundbreaking move for the industry, the FDA has authorized the marketing of ZYN nicotine pouches — the first product ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...
The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...
The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant ...